Headquartered in Midvale, UT Fiscal year ends December NASDAQ: UTMD utahmed.com
Utah Medical Products, Inc. (Nasdaq: UTMD) develops, manufactures, and markets a broad range of disposable and reusable specialty medical devices with a particular focus on health care for women and their babies. The company's products are recognized by clinicians in over one hundred countries. UTMD's product portfolio includes neonatal devices, the Filshie Clip System (for which it serves as the U.S. distributor on behalf of Femcare), biopharma pressure monitoring devices and accessories, and blood pressure monitoring kits. The company operates manufacturing facilities in the U.S., Ireland (UTMD Ltd), and the UK, and sells through a combination of direct sales to medical facilities, OEM sales to other medical device and biopharma companies, and international distributors. UTMD maintains a debt-free balance sheet with substantial cash reserves and has an active share repurchase program. Updated
Huntington Bancshares leads today's dividend payments with $313.2 million heading to shareholders, or 15.5 cents a share, landing October 1. Kulicke & Soffa, Smith & Wesson, Chemung Financial and Utah Medical are also paying out.
Utah Medical Products, Inc. (Nasdaq: UTMD) develops, manufactures, and markets a broad range of disposable and reusable specialty medical devices with a particular focus on health care for women and their babies. The company's products are recognized by clinicians in over one hundred countries.
